Abstract
The management of high-grade renal trauma remains debatable in various education and research centers, especially the cases of patients with stable hemodynamics. This paper reports the case of a 24-year-old man with high-grade renal trauma due to blunt injury in the left flank. The patient had stable hemodynamics and was managed conservatively, followed by three months of post-trauma follow up. In this case, the conservative management has resulted in a satisfactory outcome, confirming that conservative management is an appropriate alternative treatment for patients with similar cases.
Highlights
Renal trauma dominates 8-10% of abdominal trauma; 80–90% of cases are due to blunt injury [1]
There are some considerations in selecting the best management, including the hemodynamic status of the patient and whether this is any damage to other intra-abdominal organs [2,6]
This paper reports the evaluation of conservative management conducted to in a patient with high-grade renal trauma and stable hemodynamics and followed up three months post trauma
Summary
Renal trauma dominates 8-10% of abdominal trauma; 80–90% of cases are due to blunt injury [1]. There are five grades of renal trauma based on the level of damage in the cortex, medulla, blood vessels within the kidney, and in the presence of any disruption to the tubular collecting system [3]. There is ongoing debate as to whether it is appropriate to run conservative management or explorative surgery management for patients with high-grade renal trauma [5]. There are some considerations in selecting the best management, including the hemodynamic status of the patient and whether this is any damage to other intra-abdominal organs [2,6]. This paper reports the evaluation of conservative management conducted to in a patient with high-grade renal trauma and stable hemodynamics and followed up three months post trauma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Medical and Pharmaceutical Case Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.